×

Use of ultrarapid acting insulin

  • US 10,307,464 B2
  • Filed: 03/27/2015
  • Issued: 06/04/2019
  • Est. Priority Date: 03/28/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating pre-meal hyperglycemia in a patient in need of treatment who is monitored for pre-meal blood glucose levels for 10 days comprising:

  • regularly administering a split dose of an ultra rapid acting insulin formulation, the split dose including an initial dose taken at mealtime and a second dose of between 10% to 100% of the initial dosage taken 30 to 150 minutes after beginning a meal;

    wherein when pre-meal blood glucose level for a next meal had been regularly greater than 120 mg/dl.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×